Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 625.00 | 270.83 | 681.00 | 597.75 | 1.1393 | 1.2419 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 797.00 | 597.75 | 1.3333 | 1.5729 | |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 625.00 | 270.83 | 740.00 | 597.75 | 1.2380 | 1.4110 |
| BT-20 | Erlotinib | 10 | uM | 8 | 625.00 | 270.83 | 459.00 | 597.75 | 0.7679 | 0.5871 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 625.00 | 270.83 | 729.00 | 597.75 | 1.2196 | 1.3796 |
| BT-20 | Lapatinib | 10 | uM | 8 | 625.00 | 270.83 | 243.00 | 597.75 | 0.4065 | -0.0906 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 605.00 | 597.75 | 1.0121 | 1.0212 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 553.00 | 597.75 | 0.9251 | 0.8683 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 625.00 | 270.83 | 624.00 | 597.75 | 1.0439 | 1.0767 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 486.00 | 597.75 | 0.8131 | 0.6685 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 493.00 | 597.75 | 0.8248 | 0.6896 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 486.00 | 597.75 | 0.8131 | 0.6685 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 526.00 | 597.75 | 0.8800 | 0.7882 | |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 625.00 | 270.83 | 612.00 | 597.75 | 1.0238 | 1.0417 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 625.00 | 270.83 | 561.00 | 597.75 | 0.9385 | 0.8919 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 625.00 | 270.83 | 275.00 | 597.75 | 0.4601 | 0.0135 |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 625.00 | 270.83 | 420.00 | 597.75 | 0.7026 | 0.4684 |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 625.00 | 270.83 | 731.00 | 597.75 | 1.2229 | 1.3853 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 625.00 | 270.83 | 778.00 | 597.75 | 1.3015 | 1.5191 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 625.00 | 270.83 | 735.00 | 597.75 | 1.2296 | 1.3968 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 625.00 | 270.83 | 225.00 | 597.75 | 0.3764 | -0.1498 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 625.00 | 270.83 | 813.00 | 597.75 | 1.3601 | 1.6181 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 625.00 | 270.83 | 852.00 | 597.75 | 1.4253 | 1.7277 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 625.00 | 270.83 | 785.00 | 597.75 | 1.3133 | 1.5389 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 625.00 | 270.83 | 685.00 | 597.75 | 1.1460 | 1.2534 |